Fox Chase Cancer Center

Segmed, Inc. is a company based in Menlo Park, California, that specializes in providing cloud-based solutions for accessing curated and anonymized radiology data. Established in 2019, Segmed offers customized datasets tailored to the specific needs of its clients in the pharmaceutical and medical device sectors. Its platform supports the development of predictive models and enhances patient recruitment and data management, facilitating research and regulatory processes within the life sciences and technology industries. By focusing on de-identified and structured medical imaging data, Segmed aims to improve early disease detection and prediction while ensuring that findings are accessible and representative of diverse populations.

Nucleus RadioPharma is a company focused on enhancing the accessibility of radiopharmaceuticals for cancer patients. It specializes in developing innovative technologies aimed at modernizing the clinical development, manufacturing, and supply chain processes associated with radiopharmaceutical therapies. By streamlining these aspects, Nucleus RadioPharma seeks to improve the delivery of novel treatments, thereby enabling healthcare professionals to more effectively diagnose and treat various cancer diseases.